Prestige Consumer Healthcare (PBH) SVP sells 1,000 common shares

Rhea-AI Filing Summary

Prestige Consumer Healthcare Inc. Senior VP of Operations Jeffrey Zerillo reported an open-market sale of common stock. On February 11, 2026, he sold 1,000 shares of Prestige Consumer common stock at $65.93 per share. After this transaction, he directly owned 41,048 shares of the company’s common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zerillo Jeffrey

(Last) (First) (Middle)

660 WHITE PLAINS ROAD

(Street)

TARRYTOWN NY 10591

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP Operations

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/11/2026		S		1,000	D	$65.93	41,048	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jeffrey Zerillo by William P'Pool as attorney-in-fact pursuant to power of attorney dated August 7, 2018 on file with the Commission	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did PBH report in this Form 4?

PBH reported an insider stock sale. Senior VP of Operations Jeffrey Zerillo sold 1,000 shares of Prestige Consumer common stock in an open-market transaction, as disclosed in the Form 4 filing for February 11, 2026.

How many Prestige Consumer (PBH) shares did the executive sell?

The executive sold 1,000 PBH shares. Senior VP of Operations Jeffrey Zerillo executed an open-market sale of 1,000 shares of Prestige Consumer common stock at a reported price of $65.93 per share.

At what price were the PBH shares sold by the Prestige executive?

The PBH shares were sold at $65.93 each. The Form 4 shows Senior VP of Operations Jeffrey Zerillo completed an open-market sale of 1,000 Prestige Consumer common shares at a transaction price of $65.93 per share.

How many PBH shares does the reporting person hold after the sale?

He holds 41,048 PBH shares after the sale. Following the open-market sale of 1,000 Prestige Consumer common shares, Senior VP of Operations Jeffrey Zerillo directly owned a remaining balance of 41,048 common shares.

What is Jeffrey Zerillo’s role at Prestige Consumer Healthcare (PBH)?

He is Senior VP of Operations at PBH. The Form 4 identifies reporting person Jeffrey Zerillo as an officer of Prestige Consumer Healthcare Inc., serving in the role of Senior Vice President, Operations.

Was the PBH insider transaction a buy or a sell?

The PBH insider transaction was a stock sale. The Form 4 lists transaction code "S" and describes it as an open-market sale, indicating that 1,000 Prestige Consumer common shares were sold rather than acquired.